V65I (p.Val65Ile) variant of AGTR1 (Type-1 angiotensin II receptor)

V65I (p.Val65Ile) in AGTR1 (Type-1 angiotensin II receptor) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Renal tubular dysgenesis; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data and structural context.

V65I (p.Val65Ile) variant details